Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.71 2.71%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Operating Cash Flow 2011-2024 | PLX

Annual Operating Cash Flow Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.32 M -25 M -10.3 M -26.1 M -19.4 M -7.74 M -9.99 M -32.1 M -24.3 M -29.3 M -30.7 M 635 K -23.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
635 K -32.1 M -18.4 M

Quarterly Operating Cash Flow Protalix BioTherapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - -3 M - -22.4 M -13.2 M -5.83 M - -5.2 M -3.32 M -9.83 M - -18.6 M -15 M -7.12 M - -15.7 M -12.4 M -7.28 M - -3.74 M -17.4 M -9.41 M - -27.6 M -17 M -8.43 M - -24.8 M -21.3 M -9.62 M - -20.4 M -11.8 M -6.42 M - - - - - - - -9.59 M - -1.19 M 6.84 M -6.28 M - -17 M -8.81 M -3.99 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
6.84 M -27.6 M -11.1 M